ARV-110: An oral androgen receptor PROTAC degrader for prostate cancer.

Neklesa, T; Snyder, LB; Willard, RR; Vitale, N; Pizzano, J; Gordon, DA; Bookbinder, M; Macaluso, J; Dong, HQ; Ferraro, C; Wang, G; Wang, J; Crews, CM; Houston, J; Crew, AP; Taylor, I

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (7):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索